These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 24112272)

  • 1. End of treatment response in chronic hepatitis C patients treated with interferon alpha and ribavirin.
    Tanveer A; Khalid SR; Kazmi SY; Faheem S
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):764-5. PubMed ID: 24112272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.
    Halfon P; Khiri H; Tran A; Pénaranda G; Courcambeck J; Joly H; Ouzan D
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1067-71. PubMed ID: 14501613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection.
    Abe H; Aida Y; Ishiguro H; Yoshizawa K; Seki N; Miyazaki T; Itagaki M; Sutoh S; Ika M; Kato K; Shimada N; Tsubota A; Aizawa Y
    J Med Virol; 2013 Sep; 85(9):1523-33. PubMed ID: 23775277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.
    Giannini EG; Basso M; Savarino V; Picciotto A
    Aliment Pharmacol Ther; 2010 Feb; 31(4):502-8. PubMed ID: 19925499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-treatment of children with chronic hepatitis C who did not respond to interferon-alpha treatment.
    Gerner P; Hilbich J; Wenzl TG; Behrens R; Walther F; Kliemann G; Enninger A; Wirth S
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):187-90. PubMed ID: 20512050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-of-Treatment-Response in patients treated for hepatitis C virus with standard interferon and ribavirin based on viral load.
    Rathore MA; Hussain AB; Ghani E
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):104-7. PubMed ID: 25703752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of decompensated cirrhosis secondary to hepatitis C with antiviral therapy.
    Khokhar N; Qureshi MO; Niazi TK
    J Coll Physicians Surg Pak; 2013 Dec; 23(12):833-6. PubMed ID: 24304983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PREDICTIVE VALUE OF EARLY VIRIOLOGICAL RESPONSE FOR SUSTAINED VIRIOLOGICAL RESPONSE IN CHRONIC HEPATITIS WITH CONVENTIONAL INTERFERON THERAPY.
    Awan A; Umar M; Khaar Ht; Kulsoom A; Minhas Z; Ambreen S; Habib N; Mumtaz W; Habib F
    J Ayub Med Coll Abbottabad; 2016; 28(1):14-7. PubMed ID: 27323553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble inflammatory markers as predictors of virological response in patients with chronic hepatitis C virus infection treated with interferon-α plus ribavirin.
    Moura AS; Carmo RA; Teixeira AL; Teixeira MM; Rocha MO
    Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):38-43. PubMed ID: 21340353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience in complex therapy ribavine chronic viral hepatitis C].
    Domashenko OM
    Lik Sprava; 2011; (3-4):101-3. PubMed ID: 22416372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
    Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
    Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End treatment response with pegylated interferon among chronic hepatitis C non-responders.
    Shafi MS; Anjum J; Beg MA; Naseem S; Manzoor S; Hussain T; Abbass SA
    J Coll Physicians Surg Pak; 2011 Jun; 21(6):334-7. PubMed ID: 21711987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evolution of hepatitis C treatment: individualized therapy.
    Smith JR; Herrera JL
    Am J Gastroenterol; 2000 Sep; 95(9):2383. PubMed ID: 11007249
    [No Abstract]   [Full Text] [Related]  

  • 19. Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.
    Sylvestre DL; Clements BJ; Malibu Y
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1057-63. PubMed ID: 16957511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection.
    Beckebaum S; Cicinnati VR; Karliova M; Dirsch O; Erim Y; Frilling A; Malago M; Broelsch CE; Treichel U; Gerken G
    Transplant Proc; 2003 Sep; 35(6):2080-1. PubMed ID: 14529846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.